Acute and late toxicity of patients with inflammatory bowel disease undergoing irradiation for abdominal and pelvic neoplasms

Christopher G. Willett, Choon Jin Ooi, Anthony L. Zietman, Vandana Menon, Saveli Goldberg, Bruce E. Sands, Daniel K. Podolsky

Research output: Contribution to journalArticle

94 Citations (Scopus)

Abstract

Purpose: Little data exists in the medical literature describing the response of patients with inflammatory bowel disease (IBD) to abdominal and pelvic irradiation. To clarify the use of this modality in this setting, this study assesses the short- and long-term tolerance of 28 patients with IBD to abdominal and pelvic irradiation. Methods and Materials: From 1970 to 1999, 28 patients with IBD (10 patients-Crohn's disease, 18 patients-ulcerative colitis) were identified and underwent external beam abdominal or pelvic irradiation. Mean follow-up time after radiation therapy was 32 months. Patients were treated either by specialized techniques (16 patients) to minimize small and large bowel irradiation or by more conventional approaches (12 patients). Acute and late toxicity was scored. Results: The overall incidence of severe toxicity was 46% (13/28 patients). Six of 28 patients (21%) experienced severe acute toxicity necessitating cessation of radiation therapy. Late toxicity requiring hospitalization or surgical intervention was observed in 8 of 28 patients (29%). One patient experienced both an acute as well as late toxicity. For patients undergoing radiation therapy by conventional approaches, the 5-year actuarial rate of late toxicity was 73%. This figure was 23% for patients treated by specialized techniques (p = 0.02). Conclusions: Because of the potentially severe toxicity experienced by patients with IBD undergoing abdominal and pelvic irradiation, judicious use of this modality must be employed. Definition of IBD location and activity as well as careful attention to irradiation technique may allow treatment of these patients with acceptable rates of morbidity. Copyright (C) 2000 Elsevier Science Inc.

Original languageEnglish (US)
Pages (from-to)995-998
Number of pages4
JournalInternational Journal of Radiation Oncology Biology Physics
Volume46
Issue number4
DOIs
StatePublished - Mar 1 2000

Fingerprint

Abdominal Neoplasms
Pelvic Neoplasms
neoplasms
Inflammatory Bowel Diseases
toxicity
irradiation
radiation therapy
Radiotherapy

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Radiation

Cite this

Acute and late toxicity of patients with inflammatory bowel disease undergoing irradiation for abdominal and pelvic neoplasms. / Willett, Christopher G.; Ooi, Choon Jin; Zietman, Anthony L.; Menon, Vandana; Goldberg, Saveli; Sands, Bruce E.; Podolsky, Daniel K.

In: International Journal of Radiation Oncology Biology Physics, Vol. 46, No. 4, 01.03.2000, p. 995-998.

Research output: Contribution to journalArticle

Willett, Christopher G. ; Ooi, Choon Jin ; Zietman, Anthony L. ; Menon, Vandana ; Goldberg, Saveli ; Sands, Bruce E. ; Podolsky, Daniel K. / Acute and late toxicity of patients with inflammatory bowel disease undergoing irradiation for abdominal and pelvic neoplasms. In: International Journal of Radiation Oncology Biology Physics. 2000 ; Vol. 46, No. 4. pp. 995-998.
@article{8776a0f713ad44ffa4ef128eb046076a,
title = "Acute and late toxicity of patients with inflammatory bowel disease undergoing irradiation for abdominal and pelvic neoplasms",
abstract = "Purpose: Little data exists in the medical literature describing the response of patients with inflammatory bowel disease (IBD) to abdominal and pelvic irradiation. To clarify the use of this modality in this setting, this study assesses the short- and long-term tolerance of 28 patients with IBD to abdominal and pelvic irradiation. Methods and Materials: From 1970 to 1999, 28 patients with IBD (10 patients-Crohn's disease, 18 patients-ulcerative colitis) were identified and underwent external beam abdominal or pelvic irradiation. Mean follow-up time after radiation therapy was 32 months. Patients were treated either by specialized techniques (16 patients) to minimize small and large bowel irradiation or by more conventional approaches (12 patients). Acute and late toxicity was scored. Results: The overall incidence of severe toxicity was 46{\%} (13/28 patients). Six of 28 patients (21{\%}) experienced severe acute toxicity necessitating cessation of radiation therapy. Late toxicity requiring hospitalization or surgical intervention was observed in 8 of 28 patients (29{\%}). One patient experienced both an acute as well as late toxicity. For patients undergoing radiation therapy by conventional approaches, the 5-year actuarial rate of late toxicity was 73{\%}. This figure was 23{\%} for patients treated by specialized techniques (p = 0.02). Conclusions: Because of the potentially severe toxicity experienced by patients with IBD undergoing abdominal and pelvic irradiation, judicious use of this modality must be employed. Definition of IBD location and activity as well as careful attention to irradiation technique may allow treatment of these patients with acceptable rates of morbidity. Copyright (C) 2000 Elsevier Science Inc.",
author = "Willett, {Christopher G.} and Ooi, {Choon Jin} and Zietman, {Anthony L.} and Vandana Menon and Saveli Goldberg and Sands, {Bruce E.} and Podolsky, {Daniel K.}",
year = "2000",
month = "3",
day = "1",
doi = "10.1016/S0360-3016(99)00374-0",
language = "English (US)",
volume = "46",
pages = "995--998",
journal = "International Journal of Radiation Oncology Biology Physics",
issn = "0360-3016",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - Acute and late toxicity of patients with inflammatory bowel disease undergoing irradiation for abdominal and pelvic neoplasms

AU - Willett, Christopher G.

AU - Ooi, Choon Jin

AU - Zietman, Anthony L.

AU - Menon, Vandana

AU - Goldberg, Saveli

AU - Sands, Bruce E.

AU - Podolsky, Daniel K.

PY - 2000/3/1

Y1 - 2000/3/1

N2 - Purpose: Little data exists in the medical literature describing the response of patients with inflammatory bowel disease (IBD) to abdominal and pelvic irradiation. To clarify the use of this modality in this setting, this study assesses the short- and long-term tolerance of 28 patients with IBD to abdominal and pelvic irradiation. Methods and Materials: From 1970 to 1999, 28 patients with IBD (10 patients-Crohn's disease, 18 patients-ulcerative colitis) were identified and underwent external beam abdominal or pelvic irradiation. Mean follow-up time after radiation therapy was 32 months. Patients were treated either by specialized techniques (16 patients) to minimize small and large bowel irradiation or by more conventional approaches (12 patients). Acute and late toxicity was scored. Results: The overall incidence of severe toxicity was 46% (13/28 patients). Six of 28 patients (21%) experienced severe acute toxicity necessitating cessation of radiation therapy. Late toxicity requiring hospitalization or surgical intervention was observed in 8 of 28 patients (29%). One patient experienced both an acute as well as late toxicity. For patients undergoing radiation therapy by conventional approaches, the 5-year actuarial rate of late toxicity was 73%. This figure was 23% for patients treated by specialized techniques (p = 0.02). Conclusions: Because of the potentially severe toxicity experienced by patients with IBD undergoing abdominal and pelvic irradiation, judicious use of this modality must be employed. Definition of IBD location and activity as well as careful attention to irradiation technique may allow treatment of these patients with acceptable rates of morbidity. Copyright (C) 2000 Elsevier Science Inc.

AB - Purpose: Little data exists in the medical literature describing the response of patients with inflammatory bowel disease (IBD) to abdominal and pelvic irradiation. To clarify the use of this modality in this setting, this study assesses the short- and long-term tolerance of 28 patients with IBD to abdominal and pelvic irradiation. Methods and Materials: From 1970 to 1999, 28 patients with IBD (10 patients-Crohn's disease, 18 patients-ulcerative colitis) were identified and underwent external beam abdominal or pelvic irradiation. Mean follow-up time after radiation therapy was 32 months. Patients were treated either by specialized techniques (16 patients) to minimize small and large bowel irradiation or by more conventional approaches (12 patients). Acute and late toxicity was scored. Results: The overall incidence of severe toxicity was 46% (13/28 patients). Six of 28 patients (21%) experienced severe acute toxicity necessitating cessation of radiation therapy. Late toxicity requiring hospitalization or surgical intervention was observed in 8 of 28 patients (29%). One patient experienced both an acute as well as late toxicity. For patients undergoing radiation therapy by conventional approaches, the 5-year actuarial rate of late toxicity was 73%. This figure was 23% for patients treated by specialized techniques (p = 0.02). Conclusions: Because of the potentially severe toxicity experienced by patients with IBD undergoing abdominal and pelvic irradiation, judicious use of this modality must be employed. Definition of IBD location and activity as well as careful attention to irradiation technique may allow treatment of these patients with acceptable rates of morbidity. Copyright (C) 2000 Elsevier Science Inc.

UR - http://www.scopus.com/inward/record.url?scp=0033995057&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033995057&partnerID=8YFLogxK

U2 - 10.1016/S0360-3016(99)00374-0

DO - 10.1016/S0360-3016(99)00374-0

M3 - Article

C2 - 10705022

AN - SCOPUS:0033995057

VL - 46

SP - 995

EP - 998

JO - International Journal of Radiation Oncology Biology Physics

JF - International Journal of Radiation Oncology Biology Physics

SN - 0360-3016

IS - 4

ER -